Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits
- PMID: 10799583
- PMCID: PMC110861
- DOI: 10.1128/jvi.74.11.5091-5100.2000
Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits
Abstract
We have described an oligomeric gp140 envelope glycoprotein from human immunodeficiency virus type 1 that is stabilized by an intermolecular disulfide bond between gp120 and the gp41 ectodomain, termed SOS gp140 (J. M. Binley, R. W. Sanders, B. Clas, N. Schuelke, A. Master, Y. Guo, F. Kajumo, D. J. Anselma, P. J. Maddon, W. C. Olson, and J. P. Moore, J. Virol. 74:627-643, 2000). In this protein, the protease cleavage site between gp120 and gp41 is fully utilized. Here we report the characterization of gp140 variants that have deletions in the first, second, and/or third variable loop (V1, V2, and V3 loops). The SOS disulfide bond formed efficiently in gp140s containing a single loop deletion or a combination deletion of the V1 and V2 loops. However, deletion of all three variable loops prevented formation of the SOS disulfide bond. Some variable-loop-deleted gp140s were not fully processed to their gp120 and gp41 constituents even when the furin protease was cotransfected. The exposure of the gp120-gp41 cleavage site is probably affected in these proteins, even though the disabling change is in a region of gp120 distal from the cleavage site. Antigenic characterization of the variable-loop-deleted SOS gp140 proteins revealed that deletion of the variable loops uncovers cryptic, conserved neutralization epitopes near the coreceptor-binding site on gp120. These modified, disulfide-stabilized glycoproteins might be useful as immunogens.
Figures
Similar articles
-
Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.J Virol. 2002 Sep;76(17):8875-89. doi: 10.1128/jvi.76.17.8875-8889.2002. J Virol. 2002. PMID: 12163607 Free PMC article.
-
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.J Virol. 2000 Jan;74(2):627-43. doi: 10.1128/jvi.74.2.627-643.2000. J Virol. 2000. PMID: 10623724 Free PMC article.
-
Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein.J Virol. 2002 Aug;76(15):7760-76. doi: 10.1128/jvi.76.15.7760-7776.2002. J Virol. 2002. PMID: 12097589 Free PMC article.
-
Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions.J Virol. 2003 May;77(10):5678-84. doi: 10.1128/jvi.77.10.5678-5684.2003. J Virol. 2003. PMID: 12719560 Free PMC article.
-
CD4 activation of HIV fusion.Int J Cell Cloning. 1992 Nov;10(6):323-32. doi: 10.1002/stem.5530100603. Int J Cell Cloning. 1992. PMID: 1281202 Review.
Cited by
-
Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41.Retrovirology. 2004 Mar 9;1:3. doi: 10.1186/1742-4690-1-3. Retrovirology. 2004. PMID: 15169554 Free PMC article.
-
The path toward an HIV-1 vaccine.Porto Biomed J. 2017 Sep-Oct;2(5):150-152. doi: 10.1016/j.pbj.2017.06.002. Epub 2017 Aug 31. Porto Biomed J. 2017. PMID: 32258610 Free PMC article.
-
A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1.Elife. 2024 Apr 15;13:RP92379. doi: 10.7554/eLife.92379. Elife. 2024. PMID: 38619110 Free PMC article.
-
Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.PLoS One. 2015 Apr 7;10(4):e0122111. doi: 10.1371/journal.pone.0122111. eCollection 2015. PLoS One. 2015. PMID: 25849367 Free PMC article.
-
Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras.J Virol. 2004 Mar;78(5):2265-76. doi: 10.1128/jvi.78.5.2265-2276.2004. J Virol. 2004. PMID: 14963123 Free PMC article.
References
-
- Abacioglu Y H, Fouts T R, Laman J D, Claassen E, Pincus S H, Moore J P, Roby C A, Kamin-Lewis R, Lewis G K. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retroviruses. 1994;10:371–381. - PubMed
-
- Allaway G P, Davis-Bruno K L, Beaudry G A, Garcia E B, Wong E L, Ryder A M, Hasel K W, Gauduin M C, Koup R A, McDougal J S, Maddon P J. Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates. AIDS Res Hum Retroviruses. 1995;11:533–539. - PubMed
-
- Barnett S W, Rajasekar S, Legg H, Doe B, Fuller D H, Haynes J R, Walker C M, Steimer K S. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine. 1997;15:869–873. - PubMed
-
- Binley J M, Wyatt R, Desjardins E, Kwong P D, Hendrickson W, Moore J P, Sodroski J. Analysis of the interaction of antibodies with a conserved enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120. AIDS Res Hum Retroviruses. 1998;14:191–198. - PubMed
-
- Binley J M, Sanders R W, Clas B, Schuelke N, Master A, Guo Y, Kajumo F, Anselma D J, Maddon P J, Olson W C, Moore J P. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J Virol. 2000;74:627–643. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources